This Application claims priority of Taiwan Patent Application No. 101114541, filed on Apr. 24, 2012 and No. 101119292, filed on May 30, 2012 the entirety of which is incorporated by reference herein.
The technical field relates to an immunoassay test apparatus, and more particularly to an immunoassay test apparatus configured with a pin-film assembly and capable of fully mixing magnetic particles with working fluids.
Immunoassay is a technology for qualitatively and quantitatively analyzing a substance such as a compound, an enzyme or a protein by using an antibody as a micro biochemical detector, is applicable to quick drug testing, and mainly includes fluorescence immunoassay, radioimmunoassay and enzyme-linked immunosorbent assay (ELISA).
As for types of conventional enzyme immunoassay chips, some prior arts have disclosed a gravity type fluid driving mode, which directly uses an inert fluid to drive the working fluid without providing any power supply, so as to carry out immunoassay on the chips. Some prior arts have disclosed a mode of using a magnetic force to drive magnetic particles, where a movable magnetic unit is used to draw the magnetic particles into intervals of different working fluids for reaction, so as to carry out multi-step immune response.
The above-mentioned conventional patents, although related to immunoassay test technologies, merely have disclosed some technologies respectively. In the method and apparatus adopting the centrifugal force driving mode, reaction of the magnetic particles cannot be utilized. For the mode of using a magnetic force to drive magnetic particles, the magnetic force is used to drive the magnetic particles to enter different reaction tanks for reaction in sequence. Such a structure cannot be implemented in a centrifugal cartridge. Since the magnetic particles are attached and moved on the surface of the reaction tank, the magnetic particles cannot be fully mixed with the fluid in the reaction tank, which affects the precision of assay. Although the magnetic particles are subjected to a washing procedure during movement, the washing effect is undesirable since the magnetic particles are soaked in the fluid. As a result, the magnetic particles may carry residual fluid into a next reaction tank, thereby affecting the result of assay.
The present disclosure provides an immunoassay test apparatus, comprising a cartridge, a pin-film assembly, a plurality of magnetic particles, at least one first magnetic unit and at least one second magnetic unit.
The cartridge is capable of rotating about a reference axis, and has at least one test unit. The test units comprises a plurality of fluid chambers, a plurality of pin chambers, a microchannel structure, a buffer chamber, a detection chamber, a waste chamber, a capillary U-shaped guiding groove and a gas exhaust structure. Each of the fluid chambers stores a working fluid. Each of the pin chambers is corresponding to one of the fluid chambers, each of the pin chambers is configured with a first sealing film, and the first sealing film is used for preventing the pin chamber from communicating with the fluid chamber. The microchannel structure communicates each of the pin chambers, and the microchannel structure is used for guiding the working fluid to flow from the fluid chamber to the detection chamber. The buffer chamber is connected to the microchannel structure. The detection chamber is in communication with the buffer chamber. The waste chamber is in communication with the detection chamber. The capillary U-shaped guiding groove connects the detection chamber and the waste chamber. The gas exhaust structure is connected to the buffer chamber and the plurality of fluid chambers.
The pin-film assembly comprises a second sealing film, a plurality of pierce mechanisms, and a first actuation unit. The second sealing film is disposed on and covers one surface of the cartridge where the detection chamber is disposed. The plurality of pierce mechanisms is disposed on the second sealing film, each of the pierce mechanisms is corresponding to one of the pin chambers, and each of the pierce mechanisms comprises a pin and a flexible structure. The pin has a first position and a second position. The flexible structure is arranged for allowing the pin to move from the first position to the second position. The first actuation unit is used for driving the pin to move from the first position to the second position, and upon moving from the first position to the second position, the pin pierces the first sealing film, so that the pin chamber is in communication with the fluid chamber.
The plurality of magnetic particles is disposed inside the detection chamber, each of the magnetic particles is capable of magnetic attraction, and each of the magnetic particles has a first marked substance on a surface thereof.
The at least one first magnetic unit is disposed on one side of the detection chamber, the first magnetic unit is used for producing a magnetic field on the plurality of magnetic particles, so as to draw and attach the plurality of magnetic particles to the side of the detection chamber where the first magnetic unit is disposed.
The at least one second magnetic unit is capable of moving reciprocatingly between a third position and a fourth position. A magnetic force of the second magnetic unit is larger than that of the first magnetic unit. When the second magnetic unit is located at the fourth position, the second magnetic unit is located on one side of the detection chamber opposite to the first magnetic unit, and the second magnetic unit produces a magnetic field on the plurality of magnetic particles, so as to draw and attach the plurality of magnetic particles to the side of the detection chamber where the second magnetic unit is disposed.
In order to enable the Examiner to have a further understanding and recognition of the objectives and efficacies of the present disclosure, the present disclosure is described in detail below with reference to the accompanying drawings.
In the following detailed description, for purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of the disclosed embodiments. It will be apparent, however, that one or more embodiments may be practiced without these specific details. In other instances, well-known structures and devices are schematically shown in order to simplify the drawing. Referring to
Referring to
Referring to
In addition, the waste chamber 46 is connected to the detection chamber 45 through a capillary U-shaped guiding groove 434, and is connected to the third microchannel 433. The capillary U-shaped guiding groove 434 includes a first arc-shaped groove 4341, a second arc-shaped groove 4342, a first connection groove 4343 and a second connection groove 4344. The first arc-shaped groove 4341, the second arc-shaped groove 4342, the first connection groove 4343 and the second connection groove 4344 respectively have two opposite ends. One end of the first arc-shaped groove 4341 is connected to the detection chamber 45, and an other end of the first arc-shaped groove 4341 is bent towards a center of the cartridge 10 and is connected to one end of the first connection groove 4343. The first connection groove 4343 extends for a length towards the center of the cartridge 10, and an other end of the first connection groove 4343 is connected to one end of the second arc-shaped groove 4342. The two opposite ends of the second arc-shaped groove 4342 depart from the center of the cartridge 10, the second arc-shaped groove 4342 has a convex arc surface, the convex arc surface faces the reference axis C, and a distance D1 from the convex arc surface to the reference axis C is smaller than the distance D2 from the buffer chamber 44 to the reference axis C. An other end of the second arc-shaped groove 4342 is connected to one end of the second connection groove 4344. The second connection groove 4344 extends for a length away from the center of the cartridge 10, and an other end of the second connection groove 4344 is connected to the waste chamber 46. The first arc-shaped groove 4341, the first connection groove 4343, the second arc-shaped groove 4342, and the second connection groove 4344 are connected in series to form a capillary U-shaped guiding groove 434 of a U-shaped structure.
A plurality of magnetic particles 47 is disposed inside the detection chamber 45. Each of the magnetic particles 47 is capable of magnetic attraction, and each of the magnetic particles 47 has a first marked substance on a surface thereof. The first marked substance may be a conjunctive nucleic acid (DNA or RNA), a protein, a biomarker, an antibody, a cell, or a biomolecule.
Referring to
Referring to
Referring to
Referring to
Referring to
Referring to
The magnetic forces of the first magnetic unit 60 and the second magnetic unit 70 of the present disclosure may be designed according to different practical requirements. Table 1 shows magnetic force data obtained through measurement at different positions in a specific embodiment where permanent Nd2Fe14B magnets of different sizes are used as the first magnetic unit 60 and the second magnetic unit 70 of the present disclosure.
Here, 0 mm represents the magnet surface, where the magnetic force is the largest. As the distance increases, the magnetic force gradually decreases. In the present disclosure, a permanent Nd2Fe14B magnet of diameter 8 mm×2 mm is used as the first magnetic unit 60, and fixed on the tray 20, a distance from the permanent Nd2Fe14B magnet to the magnetic particles is about 2.5 mm, and the magnetic force is 946 Gauss, which is sufficient to draw and maintain the magnetic particles 47 on the first side wall 451 of the detection chamber 45. In addition, a permanent Nd2Fe14B magnet of diameter 8 mm×10 mm is used as the second magnetic unit 70, and fixed on the second actuator 87. When the second magnetic unit 40 is lifted to the fourth position P4 (the position of the second magnetic unit 70 as shown in
Referring to
Referring to
Table 2 shows a specific embodiment of an experimental flow chart of steps executed in the present disclosure, where the magnetic particles used in this experiment are magnetic ferric oxide nanoparticles, the magnetic particles have an average particle size of 180 nm and a ferric oxide concentration of 1.59 μg/μL, the amount of the magnetic particles used in the detection chamber is 100 μg, and a detection antibody is diluted to a concentration of 0.5 ng/μL. Table 2 shows various detailed parameters used in the steps such as working fluids, rotation rate of the cartridge, revolutions of the cartridge, waiting time, number of times of movement of the second magnetic unit, mixing time of the magnetic particles, rotation rate for discharging, revolutions for discharging and discharging time.
Here, No. 1 to No. 8 represent a first fluid tank to an eighth fluid tank, each of the fluid tanks stores a required working fluid in a sealed manner, IO beads-63 μL represents a magnetic particle diluent, Lysis samples-62 μL is diluted blood, Ab-62 μL is a detection antibody diluent, TMB-62 μL represents a developing solution, and Wash-62 μL is a washing solution.
First, the pin-film assembly pierces the working fluid (IO beads-63 μL, magnetic particle diluent) of the first fluid tank, and the cartridge is rotated at 2000 rpm for 100 revolutions in 3 seconds, so that the working fluid of the first fluid tank is driven by the centrifugal force to flow into the detection chamber. By capillary action, a part of the magnetic particle diluent is gradually introduced into the capillary U-shaped guiding groove. After a waiting time of 30 seconds, the cartridge is driven to rotate again (2000 rpm, 1000 revolutions, and 30 seconds), so as to discharge the magnetic particle diluent (not containing any magnetic particle) into the waste chamber. During rotation, the magnetic particles inside the detection chamber are always drawn onto the side wall of the detection chamber by the fixed first magnetic unit, waiting for reaction with a next working fluid.
Then, the pin-film assembly pierces the working fluid (Lysis samples-62 μL, diluted blood) of the second fluid tank, and the cartridge is rotated at 2000 rpm for 100 revolutions in 3 seconds, so as to introduce the working fluid (Lysis samples-62 μL, diluted blood) of the second fluid tank into the detection chamber. The second magnetic unit is driven to move vertically in a reciprocating manner, for 30 times in 10 minutes, so that the magnetic particles are uniformly mixed in the working fluid (Lysis samples-62 μL, diluted blood). After reaction is finished, a discharging procedure is executed by the centrifugal force (2000 rpm, 1000 revolutions, and 30 seconds). Likewise, the magnetic particles are maintained inside the detection chamber during discharging.
Secondly, the pin-film assembly pierces the third to eighth fluid tanks in sequence, so that different working fluids shown in Table 2 flow into the detection chamber. The magnetic particles inside the detection chamber are driven to repeatedly move to-and-fro, so that the magnetic particles undergo reaction, washing and color reaction in sequence. Finally, the optical detection system interprets light transmission for the solution inside the detection chamber.
According to the Beer-Lambert law, transmissivity T=(I/Io), and absorbance A=−log(I/Io)=ε*b*c, where I is intensity of transmitted light, and Io is intensity of incident light. When a light ray is incident on a sample solution, a part of the light ray is absorbed by the sample solution, and the remaining part of the light ray is transmitted through the sample solution. When a parallel monochromatic light ray passes through a solution, absorbance (A) of the solution is in direct proportion to a product of multiplying molar absorptivity (ε), optical path length (b) and solution concentration (c). The Beer-Lambert law is the basis of spectrophotometric quantitative analysis. After a blank sample, a high-concentration sample and a low-concentration sample undergo reaction at the cartridge, data collected by the optical detection system is as shown in
Based on the above, the immunoassay test apparatus provided in the present disclosure relates to a flow path structure, a magnetic particle mixing mechanism and a pore apparatus related to immunoassay, a flow path structure driven by a centrifugal force and a capillary force, a system for sequentially performing centrifugal quantization, magnetic particle mixing, discharging and analysis for a specimen or tested working fluid, and a method and a flow path structure thereof, and which may be used as a carrier for immunological or biochemical test. Particularly, through a magnetic unit attraction step and a magnetic particle mixing step, an antibody on the magnetic particle can be sequentially bound to an antigen of the working fluid, bound to an enzyme-labeled detection antibody, and finally mixed with an enzyme-substrate hydrolysis developing solution for color reaction.
In the present disclosure, a sequence of working fluids is sealed in the cartridge in advanced, and then delivered to a user, who performs a film piercing operation through the pin-film assembly, so that the working fluids flow into the detection chamber. Next, the magnetic particles are mixed and react with different working fluids, thereby achieving quantitative color reaction for the specimen. In the present disclosure, through proper cooperation of the microchannel structure, the centrifugal force, the fixed first magnetic unit and the movable second magnetic unit, the magnetic particles will not be carried away by the working fluid during discharging, but are maintained on the side wall of the detection chamber. After another working fluid is driven by the centrifugal force to the detection chamber, the movable magnetic unit is moved towards and away from the detection chamber to cooperate with the fixed magnetic unit, to draw and move the magnetic particles between two side walls, so as to mix the magnetic particles with the working fluids, thereby improving the test yield.
It will be apparent to those skilled in the art that various modifications and variations can be made to the disclosed embodiments. It is intended that the specification and examples be considered as exemplary only, with a true scope of the disclosure being indicated by the following claims and their equivalents.
Number | Date | Country | Kind |
---|---|---|---|
101114541 A | Apr 2012 | TW | national |
101119292 A | May 2012 | TW | national |
Number | Name | Date | Kind |
---|---|---|---|
5061381 | Burd | Oct 1991 | A |
5160702 | Kopf-Sill et al. | Nov 1992 | A |
5173193 | Schembri | Dec 1992 | A |
5186844 | Burd et al. | Feb 1993 | A |
5275016 | Chatterjee et al. | Jan 1994 | A |
5304348 | Burd et al. | Apr 1994 | A |
5409665 | Burd | Apr 1995 | A |
5413732 | Buhl et al. | May 1995 | A |
5472603 | Schembri | Dec 1995 | A |
5478750 | Bernstein et al. | Dec 1995 | A |
5590052 | Kopf-Sill et al. | Dec 1996 | A |
5591643 | Schembri | Jan 1997 | A |
6454970 | Ohman et al. | Sep 2002 | B1 |
6620478 | Ohman | Sep 2003 | B1 |
6632656 | Thomas et al. | Oct 2003 | B1 |
6811736 | Ohman et al. | Nov 2004 | B1 |
6818415 | Chiang | Nov 2004 | B2 |
6878255 | Wang et al. | Apr 2005 | B1 |
6878555 | Andersson et al. | Apr 2005 | B2 |
6884395 | Tooke et al. | Apr 2005 | B2 |
7169360 | Ågren et al. | Jan 2007 | B2 |
7177767 | Ostoich et al. | Feb 2007 | B2 |
7189368 | Andersson et al. | Mar 2007 | B2 |
7238255 | Derand et al. | Jul 2007 | B2 |
7261858 | Ågren et al. | Aug 2007 | B2 |
7261859 | Andersson et al. | Aug 2007 | B2 |
7273590 | Yao et al. | Sep 2007 | B2 |
7429354 | Andersson et al. | Sep 2008 | B2 |
7553393 | Derand et al. | Jun 2009 | B2 |
7708881 | Yu | May 2010 | B2 |
7776267 | Lee et al. | Aug 2010 | B2 |
7790110 | Cho et al. | Sep 2010 | B2 |
7819138 | Lee et al. | Oct 2010 | B2 |
7951332 | Cho et al. | May 2011 | B2 |
7951333 | Lee et al. | May 2011 | B2 |
7981385 | Park et al. | Jul 2011 | B2 |
7988915 | Lee et al. | Aug 2011 | B2 |
20050221281 | Ho | Oct 2005 | A1 |
20080058192 | Cho et al. | Mar 2008 | A1 |
20080073546 | Andersson et al. | Mar 2008 | A1 |
20080112855 | Lee et al. | May 2008 | A1 |
20080226504 | Park et al. | Sep 2008 | A1 |
20080269077 | Lee et al. | Oct 2008 | A1 |
20090209752 | Peters et al. | Aug 2009 | A1 |
20100055766 | Hwang et al. | Mar 2010 | A1 |
20100068735 | Kim et al. | Mar 2010 | A1 |
20100081213 | Lee et al. | Apr 2010 | A1 |
20110085950 | Lee et al. | Apr 2011 | A1 |
20110121196 | Yeo et al. | May 2011 | A1 |
20110124128 | Oosterbroek et al. | May 2011 | A1 |
20110131830 | Inganas et al. | Jun 2011 | A1 |
20110201101 | Lee et al. | Aug 2011 | A1 |
Number | Date | Country |
---|---|---|
102170971 | Aug 2011 | CN |
517154 | Jan 2003 | TW |
594007 | Jun 2004 | TW |
201107038 | Mar 2011 | TW |
WO0243866 | Jun 2002 | WO |
Entry |
---|
Cho et, al., “Lab-on-a-disc for simultaneous analysis of blood chemistry and immunoassay”, Oct. 12-16, 2008, pp. 462-464, Twelfth International Conference on Miniaturized Systems for Chemistry and Life Sciences, San Diego, California, USA. |
Mark et, al., “Aliquoting on the centrifugal microfluidic platform based on centrifugo-pneumatic valves”, Jan. 8, 2011, pp. 1279-1288, Springer-Verlag. |
Ducr'ee et, al., “The centrifugal microfluidic Bio-Disk platform”, Jun. 28, 2007, pp. s103-s115, Journal of Micromechanics and Microengineering. |
Honda et, al., “Simultaneous Multiple Immunoassays in a Compact Disc—Shaped Microfluidic Device Based on Centrifugal Force”, 2005, pp. 1955-1961, Oak Ridge Conference. |
Schembri et, al., “Centrifugation and capillarity integrated into a multiple analyte whole blood analyser”, May-Jun. 1995, pp. 99-104, vol. 17, Journal of Automatic Chemistry. |
Gorkin et, al., “Centrifugal microfluidics for biomedical applications”, May 28, 2010, pp. 1758-1773, The Royal Society of Chemistry. |
Siegrist, Jonathan et, al., “Serial siphon valving for centrifugal microfluidic platforms”, 2010, UC Irvine Postprints, UC Irvine. |
Li et, al., “Digitized Molecular Diagnostics: Reading Disk-Based Bioassays with Standard Computer Drives”, Nov. 1, 2008, pp. 8216-8223, vol. 80, Analytical Chemistry. |
Lai et, al., “Design of a Compact Disk-like Microfluidic Platform for Enzyme-Linked Immunosorbent Assay”, Apr. 1, 2004, vol. 76, pp. 1832-1837, Analytical Chemistry. |
Brenner et, al., “Frequency-dependent transversal flow control in centrifugal microfluidics”, Oct. 14, 2004, pp. 146-150, Lab Chip. |
Sergi Morais et, al., “Multiplexed Microimmunoassays on a Digital Versatile Disk”, Jul. 15, 2009, vol. 81, pp. 5646-5654, Analytical Chemistry. |
Pallapa et, al., “Software-based quantitation of bioassays on CD”, May 27, 2010, pp. 620-623, Elsevier B.V.. |